Hyster-Yale (HY) EBITDA (2011 - 2026)

Hyster-Yale's EBITDA history runs 16 years deep, the most recent figure standing at -$28.0 million for Q1 2026.

• Quarterly EBITDA fell 231.46% year-over-year to -$28.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$71.4 million (down 139.17% YoY) and the FY2025 annual result came in at -$22.1 million, down 109.03% from the prior year.
• EBITDA was -$28.0 million for Q1 2026 at Hyster-Yale, up from -$37.2 million in the prior quarter.
• Across five years, EBITDA topped out at $95.6 million in Q2 2024 and bottomed at -$37.2 million in Q4 2025.
• A 5-year average of $21.4 million and a median of $21.3 million in 2025 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2022 — EBITDA sank 690.32% — and 2023, when it surged 474.52%.
• Hyster-Yale's EBITDA stood at $19.8 million in 2022, then surged by 145.96% to $48.7 million in 2023, then sank by 33.68% to $32.3 million in 2024, then slumped by 215.17% to -$37.2 million in 2025, then increased by 24.73% to -$28.0 million in 2026.
• Business Quant data shows HY's EBITDA at -$28.0 million in Q1 2026, -$37.2 million in Q4 2025, and $2.3 million in Q3 2025.